Pan-cancer tRNA-derived fragment CAT1 coordinates RBPMS to stabilize NOTCH2 mRNA to promote tumorigenesis

Mengqian Yu1, Jiani Yi2, Qiongzi Qiu3

  • 1Department of Respiratory Medicine, Sir Run Run Shaw Hospital and Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310016, China; Zhejiang Provincial Key Laboratory of Precision Diagnosis and Therapy for Major Gynecological Diseases, Women's Hospital and Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310006, China.

Cell Reports
|November 9, 2023
PubMed

Insights

A novel cancer-associated tRF, CAT1, is upregulated in tumors and promotes lung cancer progression by stabilizing NOTCH2 mRNA. Elevated plasma CAT1 levels indicate potential as a biomarker for lung cancer detection.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • RNA Biology

Background:

  • Transfer RNA-derived fragments (tRFs) are small non-coding RNAs implicated in disease pathophysiology.
  • The specific role of tRFs in cancer progression is not fully understood.
  • Identifying novel regulatory mechanisms in cancer is crucial for therapeutic development.

Purpose of the Study:

  • To investigate the role of tRFs in cancer progression, focusing on lung cancer.
  • To identify and characterize a specific tRF involved in tumor development and prognosis.
  • To elucidate the molecular mechanism by which this tRF influences cancer signaling pathways.

Main Methods:

  • Pan-cancer analysis to identify upregulated tRFs.
  • In vitro and in vivo experiments to assess the functional role of CAT1 in lung cancer.
  • RNA-binding protein immunoprecipitation (RIP) assays to identify interacting proteins.
  • Western blotting and qRT-PCR to measure protein and mRNA levels.
  • Analysis of patient plasma samples for biomarker potential.

Main Results:

  • A pan-cancer 3'-tRF, termed CAT1 (cancer associated tRF 1), was found to be ubiquitously upregulated in tumors and associated with poor prognosis in various cancers, including lung cancer.
  • Upregulated CAT1 binds to RBPMS, displacing NOTCH2 and inhibiting its mRNA decay via the CCR4-NOT complex.
  • Enhanced NOTCH2 expression by CAT1 promotes lung cancer cell proliferation and metastasis in vitro and in vivo.
  • Plasma CAT1 levels were significantly increased in lung cancer patients compared to controls.

Conclusions:

  • Cancer-specific upregulation of CAT1 is intrinsically linked to cancer progression.
  • A 3'-tRF (CAT1) regulates NOTCH signaling in cancer.
  • CAT1 shows significant potential as a diagnostic biomarker for lung cancer.

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
4.3K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.2K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.1K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.8K
Catenins01:23

Catenins

Catenins are characterized by multiple binding domains and dynamic structures that allow them to function as linker proteins in cell junction complexes. All catenins, except α-catenin, contain a characteristic protein sequence called the armadillo repeat and are therefore also called armadillo proteins.
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the...
2.3K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.6K